Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies

Journal of Diabetes and its Complications

Volumn 30, Issue 2, 2016, Pages 357-367

  Rodríguez, Alexander J ^a,d   Nunes, Vania Dos Santos ^b   Mastronardi, Claudio A ^a   Neeman, Teresa ^c   Paz Filho, Gilberto J ^a  

^a Australian National University   (Australia)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Adipocytokines; Adiponectin; Diabetes; Leptin; Nephropathy; Neuropathy; Retinopathy

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; ADIPOQ PROTEIN, HUMAN;

ARTICLE; BODY MASS; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIABETIC MICROVASCULAR COMPLICATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; EFFECT SIZE; EMBASE; HUMAN; MACROALBUMINURIA; MEDLINE; META ANALYSIS; MICROALBUMINURIA; NEWCASTLE OTTAWA SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN BLOOD LEVEL; QUALITY CONTROL; RATING SCALE; SCOPUS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREND STUDY; VASCULAR DISEASE; AGED; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; MALE; MIDDLE AGED;

ADIPOKINES; ADIPONECTIN; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED;

EID: 84949663616     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.11.004     Document Type: Article

References (78)

1. B. Almeida-Pititto, S.G.A. Gimeno, R.D. Freire, F.F. Ribeiro-Filho, and S.R.G. Ferreira Leptin is not associated independently with hypertension in Japanese-Brazilian women Brazilian Journal of Medical and Biological Research 39 2006 99 105
2. American Diabetes Association Standards of medical care in diabetes - 2010 Diabetes Care 33 Suppl. 1 2010 S11 S61
3. H. Asakawa, K. Tokunaga, and F. Kawakami Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients Journal of Diabetes and its Complications 15 2001 57 62
4. M. Balaskó, S. Soós, M. Székely, and E. Pétervári Leptin and aging: Review and questions with particular emphasis on its role in the central regulation of energy balance Journal of Chemical Neuroanatomy 61-62 2014 248 255
5. P.J. Boyle Diabetes mellitus and macrovascular disease: Mechanisms and mediators The American Journal of Medicine 120 9, Supplement 2 2007 S12 S17
6. U.C. Broedl, C. Lebherz, M. Lehrke, R. Stark, M. Greif, and A. Becker A.W. Leber Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques PloS One 4 3 2009 e4733
7. R.J. Brown, C.A. Meehan, and P. Gorden Leptin does not mediate hypertension associated with human obesity Cell 162 3 2015 465 466
8. J.J. Cha, Y.Y. Hyun, Y.H. Jee, M.J. Lee, K.H. Han, and Y.S. Kang D.R. Cha Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway Kidney Research and Clinical Practice 31 2012 177 185
9. A. Chait, and K.E. Bornfeldt Diabetes and atherosclerosis: Is there a role for hyperglycemia? Journal of Lipid Research 50 2009 S335 S339 (Suppl.)
10. W.B. Chan, R.C.W. Ma, N.N. Chan, M.C.Y. Ng, Z.S.K. Lee, and C.W.K. Lai J.C.N. Chan Increased leptin concentrations and lack of gender difference in type 2 diabetic patients with nephropathy Diabetes Research and Clinical Practice 64 2004 93 98
11. M. Chandran, S.A. Phillips, T. Ciaraldi, and R.R. Henry Adiponectin: More than just another fat cell hormone? Diabetes Care 26 2003 2442 2450
12. E.Y. Choe, H.J. Wang, O. Kwon, K.J. Kim, B.S. Kim, and B.W. Lee C.S. Mantzoros Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes Metabolism 62 5 2013 677 685
13. F.-M. Chung, J.C.-R. Tsai, D.-M. Chang, S.-J. Shin, and Y.-J. Lee Peripheral total and differential leukocyte count in diabetic nephropathy: The relationship of plasma leptin to leukocytosis Diabetes Care 28 2005 1710 1717
14. M. Cnop, P.J. Havel, K.M. Utzschneider, D.B. Carr, M.K. Sinha, and E.J. Boyko S.E. Kahn Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex Diabetologia 46 2003 459 469
15. R. Coppari, and C. Bjørbæk The potential of leptin for treating diabetes and its mechanism of action Nature Reviews. Drug Discovery 11 9 2012 692 708
16. T. Costacou, D. Ellis, L. Fried, and T.J. Orchard Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: A cohort study American Journal of Kidney Diseases 50 2007 721 732
17. T. Costacou, and T.J. Orchard Adiponectin: Good, bad, or just plain ugly? Kidney International 74 5 2008 549 551
18. D. Dossarps, J.M. Petit, B. Guiu, J.P. Cercueil, L. Duvillard, A.M. Bron, and C. Creuzot-Garcher Body fat distribution and adipokine secretion are not associated with diabetic retinopathy in patients with type 2 diabetes mellitus Ophthalmic Research 51 2014 42 45
19. P.J. Dyck, K.M. Kratz, J.L. Karnes, W.J. Litchy, R. Klein, and J.M. Pach F.J. Service The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study Neurology 43 1993 817 824
20. T. Ebert, and M. Fasshauer Adiponectin: Sometimes good, sometimes bad? Cardiology 118 4 2011 236 237
21. J.L. Edwards, A.M. Vincent, H.T. Cheng, and E.L. Feldman Diabetic neuropathy: Mechanisms to management Pharmacology & Therapeutics 120 2008 1 34
22. X. Fan, Q. Wu, Y. Li, Y. Hao, N. Ning, and Z. Kang L. Han Association between adiponectin concentrations and diabetic retinopathy in patients with type 2 diabetes: A meta analysis Chinese Medical Journal 127 4 2014 765 771
23. M.J. Fowler Microvascular and macrovascular complications of diabetes Clinical Diabetes 29 3 2011 116 122
24. B. Fruehwald-Schultes, W. Kern, J. Beyer, T. Forst, A. Pfützner, and A. Peters Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria Metabolism, Clinical and Experimental 48 1999 1290 1293
25. J. Frystyk, L. Tarnow, T. Krarup Hansen, H.H. Parving, and A. Flyvbjerg Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications Diabetologia 48 9 2005 1911 1918
26. H. Fujita, T. Morii, J. Koshimura, M. Ishikawa, M. Kato, and T. Miura M. Kakei Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy Endocrine Journal 53 2006 745 752
27. R.G. Gerrity, R. Natarajan, J.L. Nadler, and T. Kimsey Diabetes-induced accelerated atherosclerosis in swine Diabetes 50 7 2001 1654 1665
28. B.J. Goldstein, R.G. Scalia, and X.L. Ma Protective vascular and myocardial effects of adiponectin Nature Clinical Practice. Cardiovascular Medicine 6 1 2009 27 35
29. A. Gottsater, B. Ahren, and G. Sundkvist The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy Diabetes Care 22 11 1999 1913 1914
30. K.D.W. Group Kidney Disease: Improving Global Outcomes (KDIGO) 2012 clinical practice guideline for the evaluation and management of chronic kidney disease Kidney International 3 2013 1 150
31. T.J. Guzik, P.J. Marvar, M. Czesnikiewicz-Guzik, and R. Korbut Perivascular adipose tissue as a messenger of the brain-vessel axis: Role in vascular inflammation and dysfunction Journal of Physiology and Pharmacology 58 2007 591 610
32. H.-P. Hammes Pathophysiological mechanisms of diabetic angiopathy Journal of Diabetes and its Complications 17 2003 16 19
33. K. Hanai, T. Babazono, I. Nyumura, K. Toya, M. Ohta, and R. Bouchi Y. Iwamoto Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy Clinical and Experimental Nephrology 14 2 2010 132 136
34. K. Hanai, T. Babazono, M. Takagi, N. Yoshida, I. Nyumura, and K. Toya Y. Uchigata Obesity as an effect modifier of the association between leptin and diabetic kidney disease Journal of Diabetes Investigation 5 2 2014 213 220
35. P.J. Havel Update on adipocyte hormones: Regulation of energy balance and carbohydrate/lipid metabolism Diabetes 53 Suppl. 1 2004 S143 S151
36. J.P.T. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Statistics in Medicine 21 2002 1539 1558
37. International Diabetes Federation IDF Diabetes Atlas Retrieved 08/06/2015, from http://www.idf.org/diabetesatlas 2014
38. M. Iwaki, M. Matsuda, N. Maeda, T. Funahashi, Y. Matsuzawa, M. Makishima, and I. Shimomura Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors Diabetes 52 7 2003 1655 1663
39. A. Jamroz-Wis̈niewska, A. Gertler, G. Solomon, M.E. Wood, M. Whiteman, and J. Bełtowski Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: Role of nitric oxide and hydrogen sulfide PloS One 9 2014 e86744
40. C.-H. Jung, B.-Y. Kim, C.-H. Kim, S.-K. Kang, S.-H. Jung, and J.-O. Mok Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients Cardiovascular Diabetology 11 2012 24
41. C.-H. Jung, B.-Y. Kim, J.-O. Mok, S.-K. Kang, and C.-H. Kim Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus Journal of Diabetes Investigation 5 2014 333 339
42. K. Kato, H. Osawa, M. Ochi, Y. Kusunoki, O. Ebisui, and K. Ohno H. Makino Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy Clinical Endocrinology 68 2008 442 449
43. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, and D.L. DeMets The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years Archives of Ophthalmology 102 1984 527 532
44. H. Komaba, N. Igaki, S. Goto, K. Yokota, H. Doi, and T. Takemoto T. Goto Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function American Journal of Nephrology 26 2006 476 482
45. M.A. Kopeisy, A. H. A., and S.I. Wasfy Evaluation of leptin levels in serum of patients with non-insulin dependent diabetic nephropathy Azhar Assim Medical Journal 9 3 2011 1687 1693
46. J. Koshimura, H. Fujita, T. Narita, T. Shimotomai, M. Hosoba, and N. Yoshioka S. Ito Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy Biochemical and Biophysical Research Communications 316 2004 165 169
47. R.H. Mak, W. Cheung, R.D. Cone, and D.L. Marks Leptin and inflammation-associated cachexia in chronic kidney disease Kidney International 69 2006 794 797
48. E. Martínez-Martínez, M. Miana, R. Jurado-López, M.V. Bartolomé, F.V. Souza Neto, and M. Salaices V. Cachofeiro The potential role of leptin in the vascular remodeling associated with obesity International Journal of Obesity 38 2014 1565 1572
49. M. Matsuda, F. Kawasaki, H. Inoue, Y. Kanda, K. Yamada, and Y. Harada K. Kaku Possible contribution of adipocytokines on diabetic neuropathy Diabetes Research and Clinical Practice 66 Suppl. 1 2004 S121 S123
50. M. Matsuda, F. Kawasaki, K. Yamada, Y. Kanda, M. Saito, and M. Eto K. Kaku Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects Diabetic Medicine 21 2004 881 888
51. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement Annals of Internal Medicine 151 2009 264 269 (W264)
52. Y. Morimoto, S.M. Conroy, N.J. Ollberding, Y. Kim, U. Lim, and R.V. Cooney G. Maskarinec Ethnic differences in serum adipokine and C-reactive protein levels: The multiethnic cohort International Journal of Obesity 38 11 2014 1416 1422
53. I. Nevelsteen, A. Van den Bergh, G. Van der Mieren, A. Vanderper, K. Mubagwa, H. Bult, and P. Herijgers NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss Journal of Vascular Research 50 2013 486 497
54. K.D. Niswender, and M.A. Magnuson Obesity and the beta cell: Lessons from leptin Journal of Clinical Investigation 117 2007 2753 2756
55. Y. Okamoto, S. Kihara, N. Ouchi, M. Nishida, Y. Arita, and M. Kumada Y. Matsuzawa Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770
56. R.E. Ostlund Jr., J.W. Yang, S. Klein, and R. Gingerich Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates The Journal of Clinical Endocrinology and Metabolism 81 11 1996 3909 3913
57. N. Parveen, and I. Zia Qureshi Vascular endothelial growth factor, interleukin 6 and leptin in the serum and vitreous fluid of type 2 diabetic patients Journal of Medical Sciences (Peshawar) 21 2013 40 43
58. G.A. Payne, J.D. Tune, and J.D. Knudson Leptin-induced endothelial dysfunction: A target for therapeutic interventions Current Pharmaceutical Design 20 2014 603 608
59. G. Paz-Filho, C. Mastronardi, C.B. Franco, K.B. Wang, M.-L. Wong, and J. Licinio Leptin: Molecular mechanisms, systemic pro-inflammatory effects, and clinical implications Arquivos Brasileiros de Endocrinologia e Metabologia 56 2012 597 607
60. R. Pradeepa, J. Surendar, K. Indulekha, S. Chella, R.M. Anjana, and V. Mohan Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133) Clinical Biochemistry 48 2015 33 38
61. J. Ran, X. Xiong, W. Liu, S. Guo, Q. Li, R. Zhang, and G. Lao Increased plasma adiponectin closely associates with vascular endothelial dysfunction in type 2 diabetic patients with diabetic nephropathy Diabetes Research and Clinical Practice 88 2010 177 183
62. N. Safai, S. Eising, D.M. Hougaard, H.B. Mortensen, K. Skogstrand, and F. Pociot J. Svensson Levels of adiponectin and leptin at onset of type 1 diabetes have changed over time in children and adolescents Acta Diabetologica 52 1 2015 167 174
63. T. Saito, O. Saito, T. Kawano, H. Tamemoto, E. Kusano, M. Kawakami, and S.-E. Ishikawa Elevation of serum adiponectin and CD146 levels in diabetic nephropathy Diabetes Research and Clinical Practice 78 2007 85 92
64. R. Sari, M.K. Balci, and C. Apaydin The relationship between plasma leptin levels and chronic complication in patients with type 2 diabetes mellitus Metabolic Syndrome and Related Disorders 8 2010 499 503
65. C.D. Stehouwer, J. Lambert, A.J. Donker, and V.W. van Hinsbergh Endothelial dysfunction and pathogenesis of diabetic angiopathy Cardiovascular Research 34 1997 55 68
66. M. Swellam, M. Sayed Mahmoud And, and A. Abdel-Fatah Ali Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus Disease Markers 27 2009 269 278
67. Y.-F. Tian, W.-C. Chang, C.-H. Loh, and P.-S. Hsieh Leptin-mediated inflammatory signaling crucially links visceral fat inflammation to obesity-associated β-cell dysfunction Life Sciences 116 2014 51 58
68. K. Tsuda, and I. Nishio Leptin and nitric oxide production in normotensive and hypertensive men Obesity Research 12 2004 1223 1237
69. G. Uckaya, M. Ozata, Z. Bayraktar, V. Erten, N. Bingol, and I.C. Ozdemir Is leptin associated with diabetic retinopathy? Diabetes Care 23 2000 371 376
70. J. Van de Voorde, B. Pauwels, C. Boydens, and K. Decaluwé Adipocytokines in relation to cardiovascular disease Metabolism 62 11 2013 1513 1521
71. G. Wang, S. Gao, N. Su, J. Xu, and D. Fu Plasma adiponectin levels inversely correlate to clinical parameters in type 2 diabetes mellitus patients with macrovascular diseases Annals of Clinical & Laboratory Science 45 3 2015 287 291
72. G.A.S.B. Wells, D. O'Connell, J. Petersen, V. Welch, M. Losos, and P. Tugwell The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses Department of Epidemiology and Community Medicine, University of Ottawa, Canada 2009 http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm [Accessed 25/05/2015]
73. D.R. Whiting, L. Guariguata, C. Weil, and J. Shaw IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 Diabetes Research and Clinical Practice 94 2011 311 321
74. C. Wilson, R. Nelson, M. Nicolson, and R. Pratley Plasma leptin concentrations: No difference between diabetic Pima Indians with and without nephropathy Diabetologia 41 1998 861 862
75. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, and K. Hara T. Kadowaki The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nature Medicine 7 2001 941 946
76. D. Yazici, D. Yavuz, A.V. Ogunc, O. Sirikci, A. Toprak, O. Deyneli, and S. Akalin Serum adipokine levels in type 1 diabetic patients: Association with carotid intima media thickness Metabolic Syndrome and Related Disorders 10 1 2012 26 31
77. M.I. Yilmaz, M. Saglam, A.R. Qureshi, J.J. Carrero, K. Caglar, and T. Eyileten J. Axelsson Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin Nephrology, Dialysis, Transplantation 23 2008 1621 1627
78. M.I. Yilmaz, A. Sonmez, C. Acikel, T. Celik, N. Bingol, and M. Pinar M. Ozata Adiponectin may play a part in the pathogenesis of diabetic retinopathy European Journal of Endocrinology 151 2004 135 140